Reuters logo
BRIEF-Shenzhen Kangtai Biological Products unit receives patent license from USPTO
November 17, 2017 / 1:38 AM / a month ago

BRIEF-Shenzhen Kangtai Biological Products unit receives patent license from USPTO

Nov 17 (Reuters) - Shenzhen Kangtai Biological Products Co Ltd

* Says its unit received patent license (No. US 9,782,471 B2), for the manufacturing method of EV71 virus-like particles, from United States Patent and Trademark Office (USPTO, and patent valid until April 25, 2034

Source text in Chinese:goo.gl/snGfZ1

Further company coverage: (Beijing Headline News)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below